Polypeptides for inducing a protective immune response against Staphylococcus aureus
    4.
    发明授权
    Polypeptides for inducing a protective immune response against Staphylococcus aureus 有权
    用于诱导针对金黄色葡萄球菌的保护性免疫应答的多肽

    公开(公告)号:US07718182B2

    公开(公告)日:2010-05-18

    申请号:US11795538

    申请日:2006-01-17

    CPC分类号: C07K14/31 A61K39/00

    摘要: The present invention features polypeptides comprising an amino acid sequence structurally related to SEQ ID NO: 1 or a fragment thereof, S. aureus AhpC-AhpF compositions, and uses of such polypeptides and compositions. SEQ ID NO: 1 has a full length S. aureus AhpC sequence. A derivative of SEQ ID NO: 1 containing an amino His-tag and three additional carboxyl amino acids was found to produce a protective immune response against S. aureus. MGHHHHHHHHHHSSGHIEGRHMSLINKEILPFTAQAFDPKKDQFKEVTQE DLKGSWSVVCFYPADFSFVCPTELEDLQNQYEELQKLGVNVFSVSTDTHF VHKAWHDHSDAISKITYTMIGDPSQTITRNDVLDEATGLAQRGTFIIDPD GVVQASEINADGIGRDASTLAHKIKAAQYVRKNPGEVCPAKWEEGAKTLQ PGLDLVGKIAEQ

    摘要翻译: 本发明的特征在于包含与SEQ ID NO:1结构相关的氨基酸序列或其片段,金黄色葡萄球菌AhpC-AhpF组合物以及这些多肽和组合物的用途的多肽。 SEQ ID NO:1具有全长金黄色葡萄球菌AhpC序列。 发现含有氨基His标签和三个另外的羧基氨基酸的SEQ ID NO:1的衍生物产生针对金黄色葡萄球菌的保护性免疫应答。 Q Q H HI R H INK INK S HI Q Q Q Q

    Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Aureus
    5.
    发明申请
    Polypeptides for Inducing a Protective Immune Response Against Staphylococcus Aureus 有权
    用于诱导针对金黄色葡萄球菌的保护性免疫反应的多肽

    公开(公告)号:US20080131447A1

    公开(公告)日:2008-06-05

    申请号:US11795538

    申请日:2006-01-17

    CPC分类号: C07K14/31 A61K39/00

    摘要: The present invention features polypeptides comprising an amino acid sequence structurally related to SEQ ID NO: 1 or a fragment thereof, S. aureus AhpC-AhpF compositions, and uses of such polypeptides and compositions. SEQ ID NO: 1 has a full length S. aureus AhpC sequence. A derivative of SEQ ID NO: 1 containing an amino His-tag and three additional carboxyl amino acids was found to produce a protective immune response against S. aureus. MGHHHHHHHHHHSSGHIEGRHMSLINKEILPFTAQAFDPKKDQFKEVTQE DLKGSWSVVCFYPADFSFVCPTELEDLQNQYEELQKLGVNVFSVSTDTHF VHKAWHDHSDAISKITYTMIGDPSQTITRNDVLDEATGLAQRGTFIIDPD GVVQASEINADGIGRDASTLAHKIKAAQYVRKNPGEVCPAKWEEGAKTLQ PGLDLVGKIAEQ

    摘要翻译: 本发明的特征在于包含与SEQ ID NO:1结构相关的氨基酸序列或其片段,金黄色葡萄球菌AhpC-AhpF组合物以及这些多肽和组合物的用途的多肽。 SEQ ID NO:1具有全长金黄色葡萄球菌AhpC序列。 发现含有氨基His标签和三个另外的羧基氨基酸的SEQ ID NO:1的衍生物产生针对金黄色葡萄球菌的保护性免疫应答。

    MGHHHHHHHHHHSSGHIEGRH MSLINKEILPFTAQAFDPKKDQFKEVTQE DLKGSWSVVCFYPADFSFVCPTELEDLQNQYEELQKLGVNVFSVSTDTHF VHKAWHDHSDAISKITYTMIGDPSQTITRNDVLDEATGLAQRGTFIIDPD GVVQASEINADGIGRDASTLAHKIKAAQYVRKNPGEVCPAKWEEGAKTLQ PGLDLVGKI AEQ

      Optimized expression of HPV 52 L1 in yeast
      6.
      发明授权
      Optimized expression of HPV 52 L1 in yeast 有权
      优化酵母中HPV 52 L1的表达

      公开(公告)号:US07700103B2

      公开(公告)日:2010-04-20

      申请号:US10594064

      申请日:2005-03-18

      IPC分类号: A61K39/00 C07H21/04 C12N15/00

      摘要: Synthetic DNA molecules encoding the HPV 52 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV 52 L1 protein, wherein said polynucleotides are codon-optimized for high level expression in a yeast cell. In alternative embodiments of the invention, the nucleotide sequence of the synthetic molecule is altered to eliminate transcription termination signals that are recognized by yeast. The synthetic molecules may be used to produce HPV 52 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV 52 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity and may also be useful for treatment of existing HPV infections.

      摘要翻译: 提供了编码HPV 52 L1蛋白的合成DNA分子。 具体地,本发明提供编码HPV 52 L1蛋白的多核苷酸,其中所述多核苷酸在酵母细胞中用于高水平表达的密码子优化。 在本发明的替代实施方案中,改变合成分子的核苷酸序列以消除由酵母识别的转录终止信号。 合成分子可用于产生HPV 52病毒样颗粒(VLP),并且生产包含HPV 52 VLP的疫苗和药物组合物。 本发明的疫苗通过中和抗体和细胞介导的免疫提供对乳头瘤病毒感染的有效免疫预防,并且还可用于治疗现有的HPV感染。

      Optimized expression of HPV 31 L1 in yeast
      8.
      发明申请
      Optimized expression of HPV 31 L1 in yeast 有权
      酵母中优化HPV31 L1的表达

      公开(公告)号:US20080166371A1

      公开(公告)日:2008-07-10

      申请号:US11879905

      申请日:2007-07-19

      摘要: Synthetic DNA molecules encoding the HPV31 L1 protein are provided. Specifically, the present invention provides polynucleotides encoding HPV31 L1 protein, wherein said polynucleotides are free from internal transcription termination signals that are recognized by yeast. Also provided are synthetic polynucleotides encoding HPV31 L1 wherein the polynucleotides have been codon-optimized for high level expression in a yeast cell. The synthetic molecules may be used to produce HPV31 virus-like particles (VLPs), and to produce vaccines and pharmaceutical compositions comprising the HPV31 VLPs. The vaccines of the present invention provide effective immunoprophylaxis against papillomavirus infection through neutralizing antibody and cell-mediated immunity.

      摘要翻译: 提供编码HPV31 L1蛋白的合成DNA分子。 具体地,本发明提供编码HPV31 L1蛋白的多核苷酸,其中所述多核苷酸不含被酵母识别的内部转录终止信号。 还提供了编码HPV31 L1的合成多核苷酸,其中多核苷酸已被密码子优化用于酵母细胞中的高水平表达。 合成分子可用于产生HPV31病毒样颗粒(VLP),以及生产包含HPV31 VLP的疫苗和药物组合物。 本发明的疫苗通过中和抗体和细胞介导的免疫来提供对乳头瘤病毒感染的有效免疫预防。